Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review.
Expression Analysis of CB2-GFP BAC Transgenic Mice.
Myelin and macrophages in the PNS: An intimate relationship in trauma and disease.
Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
Interest in providing multiple sclerosis care and subspecializing in multiple sclerosis among neurology residents.
Risk factors for increased multiple sclerosis susceptibility in the Iranian population.
Effects of fingolimod in relapsing-remitting multiple sclerosis.
Interferon beta assessment in non-Chinese and Chinese subjects: Pharmacokinetics and pharmacodynamic activity of an endogenous cytokine are not race dependent.
Prevalence of temporomandibular disorders symptoms in patients with multiple sclerosis.
The Mechanisms and Applications of T Cell Vaccination for Autoimmune Diseases: a Comprehensive Review.
Characterization of the interaction between astrocytes and encephalitogenic lymphocytes during the development of experimental autoimmune encephalitomyelitis (EAE) in mice.
Nicotine might have a protective effect in the etiology of multiple sclerosis.
[The first results of a combined all-Russian study on clinical genetics of multiple sclerosis.]
Fingolimod for the treatment of relapsing multiple sclerosis.
Does jcv antibody positivity encourage cessation of natalizumab therapy in multiple sclerosis?
Presence of aberrant V<formula>_{H}</formula>6 domains in anti-interferon-γ autoantibodies in multiple sclerosis.
Weekly multimodal MRI follow-up of two multiple sclerosis active lesions presenting a transient decrease in ADC.
Management of bladder dysfunction in patients with multiple sclerosis.
Severe relapses under fingolimod treatment prescribed after natalizumab.
Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background.
Biointegrator announced that it has successfully launched Neskler® - a first generic of Gilenya® in Russia and EuroAsian Economic Union
Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients.
Treatment Effects Maintained Over Five Years in Majority of Patients with Relapsing Remitting Multiple Sclerosis who Received Genzyme’s Lemtrada® (alemtuzumab) in Clinical Trials
Cytokines and matrix metalloproteinases in the cerebrospinal fluid of patients with acute transverse myelitis: an outcome analysis.
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis.

Pages